top of page





Pipetting Samples and Test Tube
Clinical Tests
Asset 36.png


Best Tests

We specialize in providing access to approved and evidence-based

tests tailored to the individual.

Asset 38.png

Providing International Quality

Based on our international track record, you will be receiving the highest quality tests and service.

Asset 39.png

Providing a

“One-Stop Shop”

Our proficiency in diverse testing platforms generates maximal information, and efficiency in cost, time, and biosample use.

Asset 37.png


Full Service

Beyond just lab reports, We provide the full service during the entire journey of advanced lab testing.

The Journey for Advanced Clinical Lab Testing

Choosing the best tests

Getting the best samples to the lab


Asset 64.png

Genetic counselling

(if required)

Laboratory analysis

(accuracy, speed, quality assurance)

Report interpretation and support


Our Tests

Asset 49.png
Asset 46.png
Asset 45.png
Asset 54.png
Asset 43.png

Family Planning

Clinical Genetics/Genomics Panels


Cancer Risk Priority Panel (27 genes)

Cancer Risk Standard Panel (72 genes)

Cardiology Risk Panel (92 genes)

Clinical Exome (20,000+ genes)


Non-invasive Prenatal Tests

NIPT Priority Panel (Trisomy 21, 18, 13 + Aneuploides)

NIPT Extended Panel (Priority + 8 Microdeletions)


Health Screening (Future)

Pap Smear (Cytopathology)

Health Condition


Clinical Genetics/Genomics Panels (see above)

Asset 47.png

Other Conditions (Future Tests)


Haemoncology Panels

BCR-ABL Fusion

Lymphoid Panel (32 genes)

Myeloid Panel (25 genes)

Haemoncology Panel (72 genes)

Solid Tumour Panels

Breast Tumour Panel (ER, PR, HER2)

Colon Tumour Panel (KRAS, NRAS, BRAF, MSI)

Gastric Tumour Panel (KRAS, NRAS, MSI, HER2)

Lung Tumour Panel (EGFR, ALK, PD-L1)

Tumour NGS Focus Panel (19 genes)

Tumour NGS Priority Panel (52 genes)

Tumour NGS Plus Panel (161 genes)

Tumour NGS Extended Panel (523 genes)

Tumour Protein

Tumour HER-2 IHC

Tumour ALK IHC

Tumour PD-L1 IHC

Tumour MMR Panel (MLH1, MSH2, MSH6, PMS2)

Tumour DNA/RNA

Tumour EGFR Mutation (Exons 18-21)

Tumour KRAS Mutation (Exons 2-4)

Tumour NRAS Mutation (Exons 2-4)

Tumour BRAF Mutation (Exons 11, 15)

Tumour PIK3CA Mutation (Exons 9, 20)

Tumour Microsatellite Instability (MSI)

Tumour RAS Panel (KRAS, NRAS, BRAF)

Tumour BRCA Panel (BRCA1, BRCA2)

Tumour BRCA+ Panel (Tumour 11 + Blood 34 genes)

Asset 58.png

Oncology Recurrence

Liquid Biopsy Panels

Liquid Biopsy EGFR (T790M, C797S + Activating mutations)

Liquid Biopsy PIK3CA (E545K, H1047L, H1047R, E542K)

Liquid Biopsy Pan-Tumour Priority Panel (30 genes)

Liquid Biopsy Pan-Tumour Standard Panel (77 genes)

bottom of page